A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors

References

• Kari C, Chan TO, Rocha de Quadros M, Rodeck U. Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage. Cancer Res 2003; 63:1 - 5; PMID: 12517767
   PubMed Web of Science ®Google Scholar
• Pines G, Köstler WJ, Yarden Y. Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy. FEBS Lett 2010; 584:2699 - 706; http://dx.doi.org/10.1016/j.febslet.2010.04.019; PMID: 20388509
   PubMed Web of Science ®Google Scholar
• Reilly RM, Kiarash R, Sandhu J, Lee YW, Cameron RG, Hendler A, Vallis K, Gariépy J. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. J Nucl Med 2000; 41:903 - 11; PMID: 10809207
   PubMed Web of Science ®Google Scholar
• Velikyan I, Sundberg AL, Lindhe O, Höglund AU, Eriksson O, Werner E, Carlsson J, Bergström M, Långström B, Tolmachev V. Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors. J Nucl Med 2005; 46:1881 - 8; PMID: 16269603
   PubMed Web of Science ®Google Scholar
• Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 2003; 63:7870 - 5; PMID: 14633715
   PubMed Web of Science ®Google Scholar
• Kovar JL, Johnson MA, Volcheck WM, Chen J, Simpson MA. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 2006; 169:1415 - 26; http://dx.doi.org/10.2353/ajpath.2006.060324; PMID: 17003496
   PubMed Web of Science ®Google Scholar
• Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2:127 - 37; http://dx.doi.org/10.1038/35052073; PMID: 11252954
   PubMed Web of Science ®Google Scholar
• Pedersen MW, Meltorn M, Damstrup L, Poulsen HS. The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy. Ann Oncol 2001; 12:745 - 60; http://dx.doi.org/10.1023/A:1011177318162; PMID: 11484948
   PubMed Web of Science ®Google Scholar
• Wikstrand CJ, Reist CJ, Archer GE, Zalutsky MR, Bigner DD. The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target. J Neurovirol 1998; 4:148 - 58; http://dx.doi.org/10.3109/13550289809114515; PMID: 9584952
   PubMed Web of Science ®Google Scholar
• Baselga J. Targeting tyrosine kinases in cancer: the second wave. Science 2006; 312:1175 - 8; http://dx.doi.org/10.1126/science.1125951; PMID: 16728632
   PubMed Web of Science ®Google Scholar
• Cai W, Chen K, He L, Cao Q, Koong A, Chen X. Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. Eur J Nucl Med Mol Imaging 2007; 34:850 - 8; http://dx.doi.org/10.1007/s00259-006-0361-6; PMID: 17262214
   PubMed Web of Science ®Google Scholar
• Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol Cancer Ther 2007; 6:1230 - 8; http://dx.doi.org/10.1158/1535-7163.MCT-06-0741; PMID: 17431103
   PubMed Web of Science ®Google Scholar
• Nayak TK, Garmestani K, Milenic DE, Brechbiel MW. PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab. J Nucl Med 2012; 53:113 - 20; http://dx.doi.org/10.2967/jnumed.111.094169; PMID: 22213822
   PubMed Web of Science ®Google Scholar
• Nayak TK, Garmestani K, Milenic DE, Baidoo KE, Brechbiel MW. HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts. PLoS One 2011; 6:e18198; http://dx.doi.org/10.1371/journal.pone.0018198; PMID: 21464917
   PubMed Web of Science ®Google Scholar
• Gong H, Kovar J, Little G, Chen H, Olive DM. In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia 2010; 12:139 - 49; PMID: 20126472
   PubMed Web of Science ®Google Scholar
• Tolmachev V, Friedman M, Sandström M, Eriksson TL, Rosik D, Hodik M, Ståhl S, Frejd FY, Orlova A. Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J Nucl Med 2009; 50:274 - 83; http://dx.doi.org/10.2967/jnumed.108.055525; PMID: 19164241
   PubMed Web of Science ®Google Scholar
• Cai W, Niu G, Chen X. Multimodality imaging of the HER-kinase axis in cancer. Eur J Nucl Med Mol Imaging 2008; 35:186 - 208; http://dx.doi.org/10.1007/s00259-007-0560-9; PMID: 17846765
   PubMed Web of Science ®Google Scholar
• Gong H, Sampath L, Kovar JL, Olive DM. Targeting EGFR and HER2 for Molecular Imaging of Cancer. In: Schaller B, ed. Molecular Imaging: InTech; 2012:351-374.
   Google Scholar
• Yang W, Barth RF, Wu G, Ciesielski MJ, Fenstermaker RA, Moffat BA, Ross BD, Wikstrand CJ. Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clin Cancer Res 2005; 11:341 - 50; PMID: 15671565
   PubMed Web of Science ®Google Scholar
• Oliveira S, van Dongen GA, Stigter-van Walsum M, Roovers RC, Stam JC, Mali W, van Diest PJ, van Bergen en Henegouwen PM. Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody. Mol Imaging 2012; 11:33 - 46; PMID: 22418026
   PubMed Web of Science ®Google Scholar
• Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17:545 - 80; http://dx.doi.org/10.1101/gad.1047403; PMID: 12629038
   PubMed Web of Science ®Google Scholar
• Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001; 19:316 - 7; http://dx.doi.org/10.1038/86684; PMID: 11283581
   PubMed Web of Science ®Google Scholar
• Kovar JL, Volcheck W, Sevick-Muraca E, Simpson MA, Olive DM. Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem 2009; 384:254 - 62; http://dx.doi.org/10.1016/j.ab.2008.09.050; PMID: 18938129
   PubMed Web of Science ®Google Scholar
• Cheng Z, Levi J, Xiong Z, Gheysens O, Keren S, Chen X, Gambhir SS. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem 2006; 17:662 - 9; http://dx.doi.org/10.1021/bc050345c; PMID: 16704203
   PubMed Web of Science ®Google Scholar
• Chen X, Conti PS, Moats RA. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res 2004; 64:8009 - 14; http://dx.doi.org/10.1158/0008-5472.CAN-04-1956; PMID: 15520209
   PubMed Web of Science ®Google Scholar
• Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov A Jr., Josephson L, Weissleder R. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A 2004; 101:12294 - 9; http://dx.doi.org/10.1073/pnas.0401137101; PMID: 15304657
   PubMed Web of Science ®Google Scholar
• Nitin N, Rosbach KJ, El-Naggar A, Williams M, Gillenwater A, Richards-Kortum RR. Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia. Neoplasia 2009; 11:542 - 51; PMID: 19484143
   PubMed Web of Science ®Google Scholar
• Adams KE, Ke S, Kwon S, Liang F, Fan Z, Lu Y, Hirschi K, Mawad ME, Barry MA, Sevick-Muraca EM. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt 2007; 12:024017; http://dx.doi.org/10.1117/1.2717137; PMID: 17477732
   PubMed Web of Science ®Google Scholar
• Miao Z, Ren G, Liu H, Jiang L, Cheng Z. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors. J Biomed Opt 2010; 15:036007; http://dx.doi.org/10.1117/1.3432738; PMID: 20615009
   PubMedGoogle Scholar
• Barrett T, Koyama Y, Hama Y, Ravizzini G, Shin IS, Jang BS, Paik CH, Urano Y, Choyke PL, Kobayashi H. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies. Clin Cancer Res 2007; 13:6639 - 48; http://dx.doi.org/10.1158/1078-0432.CCR-07-1119; PMID: 17982120
   PubMed Web of Science ®Google Scholar
• Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 2007; 48:1501 - 10; http://dx.doi.org/10.2967/jnumed.107.042234; PMID: 17785729
   PubMed Web of Science ®Google Scholar
• Urano Y, Asanuma D, Hama Y, Koyama Y, Barrett T, Kamiya M, Nagano T, Watanabe T, Hasegawa A, Choyke PL, et al. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med 2009; 15:104 - 9; http://dx.doi.org/10.1038/nm.1854; PMID: 19029979
   PubMed Web of Science ®Google Scholar
• Zhu L, Xie J, Swierczewska M, Zhang F, Lin X, Fang X, Niu G, Lee S, Chen X. Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions. Bioconjug Chem 2011; 22:1001 - 5; http://dx.doi.org/10.1021/bc200005w; PMID: 21574650
   PubMed Web of Science ®Google Scholar
• Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol 2012; 19:3879 - 87; http://dx.doi.org/10.1245/s10434-012-2435-y; PMID: 22669455
   PubMed Web of Science ®Google Scholar
• Patel D, Lahiji A, Patel S, Franklin M, Jimenez X, Hicklin DJ, Kang X. Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface. Anticancer Res 2007; 27:5A 3355 - 66; PMID: 17970081
   PubMed Web of Science ®Google Scholar
• Lee FT, O’Keefe GJ, Gan HK, Mountain AJ, Jones GR, Saunder TH, Sagona J, Rigopoulos A, Smyth FE, Johns TG, et al. Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806. J Nucl Med 2010; 51:967 - 72; http://dx.doi.org/10.2967/jnumed.109.068395; PMID: 20484439
   PubMed Web of Science ®Google Scholar
• Xujie L, Liu Z, Jia B, Shen L, Wang F. In vivo imaging of EGFRvIII-positive tumors using 125I-labeled a novel monoclonal antibody 4G1. J Nucl Med Meeting Abstracts 2013; 54:1151
   Google Scholar
• Perera RM, Zoncu R, Johns TG, Pypaert M, Lee FT, Mellman I, Old LJ, Toomre DK, Scott AM. Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody. Neoplasia 2007; 9:1099 - 110; http://dx.doi.org/10.1593/neo.07721; PMID: 18084617
   PubMed Web of Science ®Google Scholar
• Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer-Marek G, Gandjbakhche A, Capala J. Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res 2008; 14:3840 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-07-4076; PMID: 18559604
   PubMed Web of Science ®Google Scholar
• Tolmachev V, Rosik D, Wållberg H, Sjöberg A, Sandström M, Hansson M, Wennborg A, Orlova A. Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount. Eur J Nucl Med Mol Imaging 2010; 37:613 - 22; http://dx.doi.org/10.1007/s00259-009-1283-x; PMID: 19838701
   PubMed Web of Science ®Google Scholar
• Ogawa M, Kosaka N, Choyke PL, Kobayashi H. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res 2009; 69:1268 - 72; http://dx.doi.org/10.1158/0008-5472.CAN-08-3116; PMID: 19176373
   PubMed Web of Science ®Google Scholar
• Marshall MV, Draney D, Sevick-Muraca EM, Olive DM. Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol 2010; 12:583 - 94; http://dx.doi.org/10.1007/s11307-010-0317-x; PMID: 20376568
   PubMed Web of Science ®Google Scholar
• Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, Herek JL, Schröder CP, Kosterink JG, Lub-de Hoog MN, de Vries EG. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med 2011; 52:1778 - 85; http://dx.doi.org/10.2967/jnumed.111.092833; PMID: 21990576
   PubMed Web of Science ®Google Scholar
• Gong H, Kovar JL, Baker B, Zhang A, Cheung L, Draney DR, Corrêa IR Jr., Xu MQ, Olive DM. Near-infrared fluorescence imaging of mammalian cells and xenograft tumors with SNAP-tag. PLoS One 2012; 7:e34003; http://dx.doi.org/10.1371/journal.pone.0034003; PMID: 22479502
   PubMedGoogle Scholar
• Gong H, Jarzynka MJ, Cole TJ, Lee JH, Wada T, Zhang B, Gao J, Song WC, DeFranco DB, Cheng SY, et al. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res 2008; 68:7386 - 93; http://dx.doi.org/10.1158/0008-5472.CAN-08-1545; PMID: 18794126
   PubMed Web of Science ®Google Scholar